Annual Postoperative Ultrasound May Not Be Necessary in Low-Risk Thyroid Cancer
Serum tumor markers alone can provide reliable surveillance of patients who undergo total thyroidectomy for low- and intermediate-risk papillary thyroid carcinoma.
Topics
Do Serum Sex Hormone-Binding Globulin, Testosterone Levels Affect CVD Risk in Men?
Men with elevated serum sex hormone-binding globulin or lower total testosterone levels might be at greater risk for cardiovascular disease.
Less Intensive Diabetes Treatment May Benefit Patients at Risk for Hypoglycemia
Intensive glucose-lowering therapy is prevalent among U.S. adults with diabetes and results in hospitalizations and emergency department visits for hypoglycemia.
ACP Releases Policy Statement on DOI, COI Management for Clinical Guideline Development
The American College of Physicians endorses the necessity of a comprehensive process for disclosure of potential conflicts of interest to ensure the integrity of clinical guidelines and guidance statements.
Alterations in Gut Microbiota Linked to Lower BMD in Osteoporosis
Researchers determined whether gut microbiota was associated with bone mineral density in individuals at high risk for reduced BMD and fractures.
Semen Cryopreservation an Option to Preserve Fertility in Transgender Youth
For adolescent and young adult transgender patients, semen cryopreservation may be a viable option for fertility preservation, even in patients who have already begun treatment for gender dysphoria.
Later Puberty Is Associated With Lower Bone Mineral Density Accrual
Older pubertal age was associated with lower BMD in adolescence and early adulthood, despite some catch-up during puberty.
Entractinib, a Tumor Agnostic Therapy, Receives FDA Approval
Rozlytrek is a kinase inhibitor that selectively targets ROS1 and NTRK fusions.
Diabetes Self-Management Education May Reduce Hypoglycemia Risk
Diabetes self-management education and support can cut hypoglycemia risk.
Brand-Brand Competition Has Not Reduced Prices in the Pharmaceutical Market
Brand-brand competition in the U.S. pharmaceutical market has not lowered drug list prices.
Want to read more?
Please login or register first to view this content.
Next post in Practice Management
